obesity drug news today october 2025 glp-1 The first issue of New Scientist for 2026 brings a sharp focus on to weight loss medications. It suggests that weight-loss medications should get cheaper and more accessible (with expiry of Obesity GLP-1 Market Size to

Use 2 times daily

However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)

A typical cycle may last 8-12 weeks , followed by a break of 4-6 weeks

The mechanism of GSH-mediated biofilm disruption is possibly due to a concentration-dependent increase in GSH acidity that triggers cleaving of the matrix components

An evaluation of the relationship between retinal nerve Fiber thickness, Cochlear nerve thickness, the level of tinnitus, and hearing loss in unilateral tinnitus patients

Bulletproof Labs, which opened last October, is Aspreys next big thing, an attempt to expand his self-improvement empire beyond beverages and books